Propensity Score-Matched Analysis to Identify Pathways Associated with Loss of Sodium Iodide Symporter in Papillary Thyroid Cancer
Sodium iodide symporter (NIS) expression in thyroid follicular cells plays an important role in normal physiology and radioactive iodine therapy for thyroid cancer. Loss of NIS expression is often seen in thyroid cancers and may lead to radioiodine refractoriness. To explore novel mechanisms of NIS...
Main Authors: | Fang Lee, Chi-Yu Kuo, Chung-Hsin Tsai, Shih-Ping Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/44/4/101 |
Similar Items
-
Exogenous Melatonin Protects against Oxidative Damage to Membrane Lipids Caused by Some Sodium/Iodide Symporter Inhibitors in the Thyroid
by: Aleksandra K. Gładysz, et al.
Published: (2023-08-01) -
Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway
by: Nan-Fang Luo, et al.
Published: (2024-03-01) -
Transcription Factor CREB3L1 Regulates the Expression of the Sodium/Iodide Symporter (NIS) in Rat Thyroid Follicular Cells
by: Pablo Di Giusto, et al.
Published: (2022-04-01) -
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene
by: Seul-Gi Oh, et al.
Published: (2023-09-01) -
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma
by: Rebekka Spellerberg, et al.
Published: (2022-12-01)